The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression

J Virol. 1998 Nov;72(11):9025-33. doi: 10.1128/JVI.72.11.9025-9033.1998.

Abstract

Human immunodeficiency virus infection is characterized by a progressive decline in the number of peripheral blood CD4(+) T lymphocytes, which finally leads to AIDS. This T-cell decline correlates with the degree of in vitro-induced lymphocyte apoptosis. However, such a correlation has not yet been described in feline AIDS, caused by feline immunodeficiency virus (FIV) infection. We therefore investigated the intensity of in vitro-induced apoptosis in peripheral blood lymphocytes from cats experimentally infected with a Swiss isolate of FIV for 1 year and for 6 years and from a number of long-term FIV-infected cats which were coinfected with feline leukemia virus. Purified peripheral blood lymphocytes were either cultured overnight under nonstimulating conditions or stimulated with phytohemagglutinin and interleukin-2 for 60 h. Under stimulating conditions, the isolates from the infected cats showed significantly higher relative counts of apoptotic cells than did those from noninfected controls (1-year-infected cats, P = 0.01; 6-year-infected cats, P = 0.006). The frequency of in vitro-induced apoptosis was inversely correlated with the CD4(+) cell count (P = 0. 002), bright CD8(+) cell count (P = 0.009), and CD4/CD8 ratio (P = 0. 01) and directly correlated with the percentage of bright major histocompatibility complex class II-positive peripheral blood lymphocytes (P = 0.004). However, we found no correlation between in vitro-induced apoptosis and the viral load in serum samples. Coinfection with feline leukemia virus enhanced the degree of in vitro-induced apoptosis compared with that in FIV monoinfected cats. We concluded that the degree of in vitro-induced apoptosis was closely related to FIV-mediated T-cell depletion and lymphocyte activation and could be used as an additional marker for disease progression in FIV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis*
  • Biomarkers
  • CD4-CD8 Ratio
  • Cats
  • Feline Acquired Immunodeficiency Syndrome / etiology*
  • Feline Acquired Immunodeficiency Syndrome / immunology
  • Feline Acquired Immunodeficiency Syndrome / pathology*
  • Female
  • Gene Products, gag / analysis
  • Humans
  • Immunodeficiency Virus, Feline / immunology
  • Immunodeficiency Virus, Feline / pathogenicity*
  • In Vitro Techniques
  • Lentivirus Infections / etiology*
  • Lentivirus Infections / immunology
  • Lentivirus Infections / pathology*
  • Lymphocyte Activation
  • Lymphocytes / immunology
  • Lymphocytes / pathology*
  • Lymphocytes / virology
  • Male
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Biomarkers
  • Gene Products, gag
  • Tumor Necrosis Factor-alpha
  • p24 protein, Feline immunodeficiency virus